ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,444.69
0.19%
US Tech 100
18,491.20
-0.06%
Dow Jones
39,987.68
0.56%
Brent Oil
79.465
-1.40%
Bitcoin
59,261.73
-2.24%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Sabre Corp (0A21) Quote

Sabre Corp

Sabre Corp (0A21)

LSE
0.00
0.00
(0.00%)
Closed August 14 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
-
Previous Close
-
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
379,481,000
Dividend Yield
-
PE Ratio
-2.02
Earnings Per Share (EPS)
-1.43
Revenue
2.91B
Net Profit
-541.87M

About Sabre Corp

Sector
Cmp Processing,data Prep Svc
Industry
Cmp Processing,data Prep Svc
Website
www.sabre.com
Headquarters
Southlake, Texas, USA
Founded
1970
Sabre Corp is listed in the Cmp Processing,data Prep Svc sector of the London Stock Exchange with ticker 0A21. The last closing price for Sabre was -. Over the last year, Sabre shares have traded in a share price range of 0.00 € to 0.00 €.

Sabre currently has 379,481,000 shares outstanding. Sabre has a price to earnings ratio (PE ratio) of -2.02.

0A21 Latest News

More News

Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase

MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and...

June 24 2020
GlobeNewswire Inc.

Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals

Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio  MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta...

June 09 2020
GlobeNewswire Inc.

Melinta Therapeutics Confirms Deerfield as Successful Bidder for Company

MORRISTOWN, N.J., March 04, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (the “Company” or “Melinta”), a commercial-stage company focused on the development and commercialization of novel...

March 04 2020
GlobeNewswire Inc.

Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures

Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company...

February 13 2020
GlobeNewswire Inc.

Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility

MORRISTOWN, N.J., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT) (the “Company” or “Melinta”), a commercial-stage company focused on the development and...

December 27 2019
GlobeNewswire Inc.

Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019

MORRISTOWN, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...

November 12 2019
GlobeNewswire Inc.

Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...

~ Approval Based on Positive Phase III Trial Results of BAXDELA for Treatment of CABP in Adults~ ~ Company Delays Launch of CABP Indication Until Further Visibility Into Liquidity Position ~...

October 24 2019
GlobeNewswire Inc.

Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019

Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019 52 Presentations by Coalition Members During the Annual Meeting PR Newswire WASHINGTON, Oct. 1, 2019...

October 01 2019
PR Newswire (US)

Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director

MORRISTOWN, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (Nasdaq: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics...

September 03 2019
GlobeNewswire Inc.

Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan

MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...

August 09 2019
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0R0OUnitedhealth Group Inc
$ 570.00
(129.93%)
2.72k
IXIIxico Plc
9.50p
(33.33%)
813.78k
JOGJersey Oil And Gas Plc
90.50p
(20.67%)
685.53k
CRDLCordel Group Plc
5.35p
(18.89%)
990.92k
DKEDukemount Capital Plc
0.0375p
(15.38%)
170.27M
DISDistil Plc
0.25p
(-41.18%)
23.48M
SNDSondrel (holdings) Plc
1.85p
(-20.43%)
1.61M
WEBWebis Holdings Plc
0.80p
(-15.79%)
2.61M
RMRRome Resources Plc
0.28p
(-11.11%)
9.58M
SDXSdx Energy Plc
2.60p
(-10.34%)
1.16M
ECHOEcho Energy Plc
0.0031p
(0.00%)
1.32B
GBPGlobal Petroleum Limited
0.0725p
(-9.38%)
934.03M
UKOGUk Oil & Gas Plc
0.054p
(-3.57%)
347.29M
TRPTower Resources Plc
0.016p
(-5.88%)
200.7M
UFOAlien Metals Limited
0.135p
(3.85%)
175.86M

Discussion

View Full Feed
georgie18 georgie18 25 seconds ago
NSAV...0062...WDCO to $1...

georgie18

Member Level
Re: None

Thursday, July 25, 2024 9:44:28 AM

Post#
382089
of 382618
NSAV...0038...Gonna start scaling in here with another starter...will add up or down from h
NSAV
NeutrinoKid NeutrinoKid 27 seconds ago
But most importantly, it’s 2024 just hot from the press (virtual).
RSPI
lakers17 lakers17 30 seconds ago
Yes nice on ASII. Haven't sold any yet from .0007 but getting close to taking some profit.
ASII
JusticeWillWin JusticeWillWin 30 seconds ago
🚀🚀🚀COOP to acquire MSRs/subservicing of ~$356 BILLION in UPB for $1.4 BILLION in cash from Flagstar

See: https://www.housingwire.com/articles/mr-cooper-to-acquire-flagstars-servicing-and-tpo-businesses-for-1-4b-in-cash/
COOP
jimr1717 jimr1717 39 seconds ago
You forgot the Revoked Notice from the SOS. No one is fooled by the CONdog96 🤡™

Clown. Absolutely no one
ATMH
georgejjl georgejjl 52 seconds ago
NEW PAPER

Burden of illness in Rett syndrome: initial evaluation of a disorder-specific caregiver survey

https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03313-8

Good luck and GOD bless,
AVXL
getmoreshares getmoreshares 58 seconds ago
yes- 15th
BLFR
BIOCHEMUP BIOCHEMUP 1 minute ago
Bid 1,230,000 $0.0003
Ask 589,900 $0.0009
RSPI
wadegarret wadegarret 1 minute ago
HALO($57.18) hits another new all time high

This steady eddy is just what the doctor ordered. Low PE, high growth drug delivery device company, with partnerships with the biggest pharma names ie Roche, Bistol Myers, J & J, etc. PE of 11.5, with eps growth of 25%/year expected for
timberwolf7 timberwolf7 1 minute ago
Many commies on here are doing this DAILY...A caveat is tho, many of
have yet to make yourselves 'look any good' to begin with before confirming
you are stupid and foolish..

he was back to being a stupid Buffoon and had totally ruined any positives he had coming out of
gawti88 gawti88 1 minute ago
https://twitter.com/PsyKeyworld/status/1823781857277960453?t=VqndG472BJoNp8Lk3sv64g&s=19

HOLY SH?T
CEOS
koolmc koolmc 1 minute ago
again swampy people have sold and can buy and sell in em, it's just mostly you that is supposedly stuck in a stock "voluntarily" over a year.
CNNA
georgie18 georgie18 1 minute ago
NSAV...0062...WDCO to $1...

georgie18

Member Level
Re: None

Thursday, July 25, 2024 9:44:28 AM

Post#
382089
of 382618
NSAV...0038...Gonna start scaling in here with another starter...will add up or down from h
NSAV
$theDDmessiah $theDDmessiah 2 minutes ago
Stop deleting my relevant posts
DJT
i_like_bb_stock i_like_bb_stock 2 minutes ago
CEOS https://x.com/PsyKeyworld/status/1823781857277960453
CEOS
Art67 Art67 2 minutes ago
Lol,so you think otc want to see permit?and that's the hold?
TXTM
$theDDmessiah $theDDmessiah 2 minutes ago
https://x.com/PsyKeyworld/status/1823781857277960453?s=19
DJT
$PennyMover $PennyMover 2 minutes ago
Some shares traded, 1.3 million so far.

I hope whoever bought doesn't think that this is $DSCR/digital
DSCR
MerthyrQ MerthyrQ 2 minutes ago
I believe the next financial disclosure is due out in the next few days. Perhaps many of the questions that Gdog has will be answered withing the financial statements, and more completely in the in disclosures. I suggest you read them.

The company has clearly been working hard on im
TTNN
i_like_bb_stock i_like_bb_stock 2 minutes ago
https://x.com/PsyKeyworld/status/1823781857277960453
CEOS
manibiotech manibiotech 2 minutes ago
Volume has dried up as before
Doesn’t look like going anywhere again
NWBO
i_like_bb_stock i_like_bb_stock 2 minutes ago
CEOS https://x.com/PsyKeyworld/status/1823781857277960453
CEOS

Your Recent History

LSE
0A21
Sabre
LSE
0JWM
Societe Industrielle Et ...
NASDAQ
PHTN
Photon Dynamics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved